Literature DB >> 9242648

Estrogen receptors alpha and beta form heterodimers on DNA.

S M Cowley1, S Hoare, S Mosselman, M G Parker.   

Abstract

The estrogen receptor (ER) is expressed in two forms, ERalpha and ERbeta. Here we show that ERalpha and ERbeta, expressed both in vitro and in vivo, form heterodimers which bind to DNA with an affinity (Kd of approximately 2 nM) similar to that of ERalpha and greater than that of ERbeta homodimers. Mutation analysis of the hormone binding domain of ERalpha suggests that the dimerization interface required to form heterodimers with ERbeta is very similar but not identical to that required for homodimer formation. The heterodimer, like the homodimers, are capable of binding the steroid receptor coactivator-1 when bound to DNA and stimulating transcription of a reporter gene in transfected cells. Given the relative expression of ERalpha and ERbeta in tissues and the difference in DNA binding activity between ERalpha/ERbeta heterodimers and ERbeta it seems likely that the heterodimer is functionally active in a subset of target cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242648     DOI: 10.1074/jbc.272.32.19858

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  125 in total

1.  Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex.

Authors:  G B Tremblay; A Tremblay; F Labrie; V Giguère
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 2.  Molecular mechanisms of estrogen actions on the vasculature.

Authors:  M P Haynes; K S Russell; J R Bender
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

Review 3.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

4.  Androgen receptor (AR), estrogen receptor-alpha (ER-alpha) and estrogen receptor-beta (ER-beta) expression in the testis of the newt, Triturus marmoratus marmoratus during the annual cycle.

Authors:  M I Arenas; M Royuela; M V Lobo; J M Alfaro; B Fraile; R Paniagua
Journal:  J Anat       Date:  2001-10       Impact factor: 2.610

5.  Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus.

Authors:  M C Erlandsson; C Ohlsson; J A Gustafsson; H Carlsten
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

6.  Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.

Authors:  Borja Belandia; Rob L Orford; Helen C Hurst; Malcolm G Parker
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

7.  Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.

Authors:  Xiaodong Li; Jing Huang; Ping Yi; Robert A Bambara; Russell Hilf; Mesut Muyan
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Mitochondrial localization of estrogen receptor beta.

Authors:  Shao-Hua Yang; Ran Liu; Evelyn J Perez; Yi Wen; Stanley M Stevens; Thomas Valencia; Anne-Marie Brun-Zinkernagel; Laszlo Prokai; Yvonne Will; James Dykens; Peter Koulen; James W Simpkins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

9.  The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin.

Authors:  Joëlle Rüegg; Elin Swedenborg; David Wahlström; Aurelie Escande; Patrick Balaguer; Katarina Pettersson; Ingemar Pongratz
Journal:  Mol Endocrinol       Date:  2007-11-08

10.  Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.

Authors:  Zhenwei Gu; Gang Wang; Weiguo Chen
Journal:  Tumour Biol       Date:  2014-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.